tirzepatide fishers (Mounjaro) In Sherman Oaks Fishers Clinic and Med Spa

Data Availability Statement Lilly provides access to all individual participant data collected during the trial, after anonymization, with the exception of pharmacokinetic or genetic data

A large retrospective study of over 18,000 patients found that those taking tirzepatide lost approximately 15.3% of body weight in one year compared to 8.3% with semaglutide

Choose a time for video or phone

In the STEP 1 extension study (semaglutide, similar in principle to liraglutide), participants regained approximately two-thirds of lost weight within one year of stopping the medication

The glucagon component increases thermogenesis and fat oxidation beyond what dual-receptor approaches achieve

Contact our Semaglutide weight loss center if you have additional weight loss questions